Skip to main content

EDITORIAL article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1508723
This article is part of the Research Topic Application of Multi-omics Analysis in Thoracic Cancer Immunotherapy View all 14 articles

Editorial: The Application of Multi-Omics Analysis in Thoracic Cancer Immunotherapy

Provisionally accepted
Jindong Xie Jindong Xie 1Tingting Cai Tingting Cai 2Attila Szöllősi Attila Szöllősi 3Yuan Li Yuan Li 4*Hailin Tang Hailin Tang 1*
  • 1 Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China
  • 2 Shanghai Cancer Center, Fudan University, Shanghai, Shanghai Municipality, China
  • 3 University of Debrecen, Debrecen, Hajdu-Bihar, Hungary
  • 4 Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China

The final, formatted version of the article will be published soon.

    The advent of multi-omics analysis has fundamentally transformed our understanding of thoracic 21 cancers, particularly in terms of their interactions with the immune system. Recent advancements in 22 multi-omics technologies have enabled us to gain insights into tumors at the single-cell level. For 23 instance, Spatial genomics, spatial transcriptomics, and spatial proteomics facilitate the understanding 24 of the three-dimensional molecular architecture of tumors, elucidating the intricate interactions 25 between tumor cells and the tumor microenvironment (TME)( As we look to the future, the integration of artificial intelligence (AI) and machine learning with multi-71 omics data holds significant promise(10). These technologies can enhance data analysis, enabling the 72 identification of patterns and predictive models that inform personalized treatment strategies. 73By harnessing these advancements, researchers and clinicians can better tailor immunotherapy 74 approaches to meet the unique needs of patients with thoracic cancers. 75In conclusion, multi-omics analysis represents a powerful tool in the fight against thoracic cancers, 76 particularly in enhancing our understanding of the TME and its interactions with the immune system. 77As we continue to unravel the complexities of cancer biology, the insights gained from multi-omics 78 studies will be pivotal in developing more effective and personalized immunotherapeutic strategies. 79We look forward to the ongoing innovations in this field and their potential to improve patient 80 outcomes in thoracic cancer treatment. 81

    Keywords: multi-omics, Thoracic cancer, Immunotherapy, oncology, Tumor microenvironment 20

    Received: 09 Oct 2024; Accepted: 16 Oct 2024.

    Copyright: © 2024 Xie, Cai, Szöllősi, Li and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Yuan Li, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China
    Hailin Tang, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.